Cours Pharmagreen Biotech Inc. OTC Markets
Actions
PHBI
US00922N1046
Recherche biotechnologique et médicale
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,0289 USD | -.--% | -4,87% | +172,64% |
CA 2022 | - | CA 2023 | 0 0 | Capitalisation | 401 k 367 k |
---|---|---|---|---|---|
Résultat net 2022 | - 0 | Résultat net 2023 | - 0 | VE / CA 2022 | - |
Dette nette 2022 | 331 k 302 k | Dette nette 2023 | 372 k 339 k | VE / CA 2023 | 257 842 228 x |
PER 2022 |
-4,61
x | PER 2023 |
-0,57
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 87,23% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Peter Wojcik
CEO | Chief Executive Officer | 53 | 09/12/13 |
Terry Kwan
DFI | Director of Finance/CFO | 77 | 22/07/15 |
Ethan Styles
CTO | Chief Tech/Sci/R&D Officer | - | 22/09/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Peter Wojcik
CEO | Chief Executive Officer | 53 | 09/12/13 |
Terry Kwan
DFI | Director of Finance/CFO | 77 | 22/07/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,51% | 42,75 Md | |
+8,57% | 41,34 Md | |
+49,22% | 41,61 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |
- Bourse
- Actions
- Action PHBI
- Action PHBI